Moderna, Inc. (MRNA) Stock Price, News, Quote & History - Yahoo Finance (2024)

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},m=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(m(),setInterval((function(){m()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var f=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(Qt=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===f&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Ft)),notifLabel:document.querySelector(".".concat(Gt))};no(e,n)}))}()}};

NasdaqGS - Delayed Quote • USD

148.39 -0.20 (-0.13%)

At close: June 11 at 4:00 PM EDT

148.11 -0.28 (-0.19%)

After hours: June 11 at 7:58 PM EDT

Key Events

Line

Candle

Baseline

Mountain

Bar

Advanced Chart

Loading Chart for MRNA

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

• Previous Close 148.59
• Open 148.15
• Bid 148.26 x 200
• Ask 148.48 x 400
• Day's Range 146.95 - 150.65
• 52 Week Range 62.55 - 170.47
• Volume 1,920,838
• Avg. Volume 4,011,057
• Market Cap (intraday) 56.869B
• Beta (5Y Monthly) 1.54
• PE Ratio (TTM) --
• EPS (TTM) -15.60
• Earnings Date Aug 1, 2024 - Aug 5, 2024
• Forward Dividend & Yield --
• Ex-Dividend Date --
• 1y Target Est 143.52

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

www.modernatx.com

5,600

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Moderna, Inc.

Recent News: MRNA

View More

All SEC Filings

Corporate Changes & Voting Matters

Periodic Financial Reports

Proxy Statements

Tender Offer/Acquisition Reports

Offering Registrations

See Also

Is Moderna Stock A Buy After Its Second-Ever Product Wins Approval?3 Reasons to Buy Moderna Stock | The Motley FoolCovid-flu combination vaccine shows positive results in late-stage trial, Moderna says | CNNModerna, Inc. (MRNA) Latest Press Releases & Corporate News - Yahoo Finance

View More

Performance Overview: MRNA

Trailing total returns as of 6/11/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MRNA

49.21%

S&P 500

12.69%

1-Year Return

MRNA

20.39%

S&P 500

25.04%

3-Year Return

MRNA

31.62%

S&P 500

26.80%

5-Year Return

MRNA

846.97%

S&P 500

86.21%

Compare To: MRNA

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MRNAModerna, Inc.

148.39

-0.13%

Mkt Cap 56.869B

Industry Biotechnology

NVAXNovavax, Inc.

16.73

+4.50%

Mkt Cap 2.464B

Industry Biotechnology

BNTXBioNTech SE

98.80

+0.84%

Mkt Cap 23.81B

Industry Biotechnology

VKTXViking Therapeutics, Inc.

52.73

-6.47%

Mkt Cap 5.814B

Industry Biotechnology

NVONovo Nordisk A/S

141.79

-1.28%

Mkt Cap 631.571B

Industry Biotechnology

GERNGeron Corporation

5.09

+0.99%

Mkt Cap 3.019B

Industry Biotechnology

CRSPCRISPR Therapeutics AG

62.31

+3.87%

Mkt Cap 5.291B

Industry Biotechnology

VRTXVertex Pharmaceuticals Incorporated

481.53

-0.36%

Mkt Cap 124.26B

Industry Biotechnology

RXRXRecursion Pharmaceuticals, Inc.

8.58

-0.46%

Mkt Cap 2.039B

Industry Biotechnology

VRAXVirax Biolabs Group Limited

1.6400

-15.03%

Mkt Cap 3.874M

Industry Biotechnology

REGNRegeneron Pharmaceuticals, Inc.

1,010.54

+0.88%

Mkt Cap 111.347B

Industry Biotechnology

Statistics: MRNA

View More

Valuation Measures

Annual

As of 6/10/2024

• Market Cap

  56.99B

• Enterprise Value

  49.70B

• Trailing P/E

  --

• Forward P/E

  --

• PEG Ratio (5yr expected)

  --

• Price/Sales (ttm)

  11.15

• Price/Book (mrq)

  4.45

• Enterprise Value/Revenue

  9.78

• Enterprise Value/EBITDA

  --

Financial Highlights

Profitability and Income Statement

• Profit Margin

  -115.82%

• Return on Assets (ttm)

  -15.72%

• Return on Equity (ttm)

  -37.68%

• Revenue (ttm)

  5.15B

• Net Income Avi to Common (ttm)

  -5.97B

• Diluted EPS (ttm)

  -15.60

Balance Sheet and Cash Flow

• Total Cash (mrq)

  8.52B

• Total Debt/Equity (mrq)

  9.65%

• Levered Free Cash Flow (ttm)

  -1.95B

View More

Research Analysis: MRNA

View More

View More

Company Insights: MRNA

Research Reports: MRNA

View More

View More

People Also Watch

NVAX Novavax, Inc.

16.73

+4.50%

BNTX BioNTech SE

98.80

+0.84%

ZM Zoom Video Communications, Inc.

62.85

-0.17%

NIO NIO Inc.

4.4600

-5.51%

INO Inovio Pharmaceuticals, Inc.

9.71

-0.10%

AZN AstraZeneca PLC

79.23

-1.22%

ABNB Airbnb, Inc.

147.75

-0.22%

PFE Pfizer Inc.

28.03

-0.14%

SQ Block, Inc.

64.16

-0.28%

NKLA Nikola Corporation

0.4902

-0.99%

SNOW Snowflake Inc.

128.48

+1.36%

UBER Uber Technologies, Inc.

69.59

+1.44%

ROKU Roku, Inc.

58.17

+0.50%

GILD Gilead Sciences, Inc.

64.89

-0.55%

PYPL PayPal Holdings, Inc.

64.77

-3.46%

SHOP Shopify Inc.

63.82

+1.29%